Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:24586179  

Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response.

Indroneal Banerjee | Jianlin Zhang | Thomas Moore-Morris | Emily Pfeiffer | Kyle S Buchholz | Ao Liu | Kunfu Ouyang | Matthew J Stroud | Larry Gerace | Sylvia M Evans | Andrew McCulloch | Ju Chen
PLoS genetics | 2014

Recent interest has focused on the importance of the nucleus and associated nucleoskeleton in regulating changes in cardiac gene expression in response to biomechanical load. Mutations in genes encoding proteins of the inner nuclear membrane and nucleoskeleton, which cause cardiomyopathy, also disrupt expression of a biomechanically responsive gene program. Furthermore, mutations in the outer nuclear membrane protein Nesprin 1 and 2 have been implicated in cardiomyopathy. Here, we identify for the first time a role for the outer nuclear membrane proteins, Nesprin 1 and Nesprin 2, in regulating gene expression in response to biomechanical load. Ablation of both Nesprin 1 and 2 in cardiomyocytes, but neither alone, resulted in early onset cardiomyopathy. Mutant cardiomyocytes exhibited altered nuclear positioning, shape, and chromatin positioning. Loss of Nesprin 1 or 2, or both, led to impairment of gene expression changes in response to biomechanical stimuli. These data suggest a model whereby biomechanical signals are communicated from proteins of the outer nuclear membrane, to the inner nuclear membrane and nucleoskeleton, to result in changes in gene expression required for adaptation of the cardiomyocyte to changes in biomechanical load, and give insights into etiologies underlying cardiomyopathy consequent to mutations in Nesprin 1 and 2.

Pubmed ID: 24586179

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL106968
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL096544
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS047101
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL107442
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL105373
  • Agency: NIGMS NIH HHS, United States
    Id: P50 GM094503
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM028521
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007444
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL105242
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL098053

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


129/SvJ (tool)

RRID:MGI:5659152

laboratory mouse with name 129/SvJ from MGI.

View all literature mentions